SOLOMIA PULLEN: Open Payments
NPI 1346916327 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 47 payments from 13 companies in 2025. Trend: 2023 $1,311 · 2024 $401 · 2025 $1,238
Food & beverage: $1,138Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $290 |
| Novartis Pharmaceuticals Corporation | 12 | $237 |
| GENZYME CORPORATION | 6 | $163 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| BioCryst US Sales Co., LLC | 2 | $58 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $56 |
| Optinose US, Inc. | 2 | $51 |
| CSL Behring | 2 | $44 |
Products named: DUPIXENT, TEZSPIRE, Rhapsido, FASENRA, ORLADEYO, NEFFY, Xhance, Xolair.
Industry payments across FL — which companies pay providers there.
